Evidence map›Paper›PMID 23720270›Full record

ReviewComprehensive Physiology2012

Exercise training and peripheral arterial disease.

Tara L Haas, Pamela G Lloyd, Hsiao-Tung Yang, Ronald L Terjung

Abstract readReview
In one paragraph

Review in Comprehensive Physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Modes of exercise training for intermittent claudication.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Exercise for intermittent claudication.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Article
  15. The treatment of chronic anemia in heart failure: a global approach.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Peripheral arterial disease: A small and large vessel problem.American heart journal plus : cardiology research and practice · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Tara L HaasAngiogenesis Research Group, Muscle Health Research Centre, Faculty of Health, York University, Toronto, Ontario, Canada.
Pamela G Lloyd
Hsiao-Tung Yang
Ronald L Terjung
University of Missouri · USOklahoma State University · USYork University · CA

Funding

Vascular Biology: Exercise Training and Vascular DiseaseP01HL052490 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI TERJUNG, RONALD L · 1995 to 2010
$19.3M
Exercise &Health: Integration from Molecule to PatientT32AR048523 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI TERJUNG, RONALD L · 2003 to 2013
$2.5M
Regulation of placenta growth factor by hemodynamics and reactive oxygen speciesR01HL084494 · NHLBI · OKLAHOMA STATE UNIVERSITY STILLWATER · PI LOVERN, PAMELA C · 2009 to 2013
$1.8M
EXERCISE TRAINING AND PERIPHERAL ARTERIAL INSUFFICIENCYR01HL037387 · NHLBI · UPSTATE MEDICAL UNIVERSITY · PI TERJUNG, RONALD L · 1987 to 2004
$1.8M
REMODELING OF COLLATERAL VESSELS AFTER FEMORAL OCCLUSIONF32HL010485 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI PRIOR, BARRY M · 2001 to 2003
$148k
ANGIOGENIC GROWTH FACTORS IN EXERCISING SKELETAL MUSCLEF32HL010406 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI LLOYD, PAMELA G · 2000 to 2002
$110k
ADENINE NUCLEOTIDE METABOLISM IN SKELETAL MUSCLER37AR021617 · NIAMS · UPSTATE MEDICAL UNIVERSITY · PI TERJUNG, RONALD L · 1989 to 1998
–
NHLBI NIH HHS F32 HL010406NHLBI NIH HHS F32 HL010485NHLBI NIH HHS F32-HL10406NHLBI NIH HHS F32-HL10485NHLBI NIH HHS P01 HL052490NHLBI NIH HHS P01-HL52490NHLBI NIH HHS R01 HL037387NHLBI NIH HHS R01 HL084494NHLBI NIH HHS R01-HL084494NHLBI NIH HHS R01-HL37387NIAMS NIH HHS R37 AR021617NIAMS NIH HHS R37-AR21617NIAMS NIH HHS T32 AR048523NIAMS NIH HHS T32-AR048523
6 · The paper itself

Abstract

Peripheral arterial disease (PAD) is a common vascular disease that reduces blood flow capacity to the legs of patients. PAD leads to exercise intolerance that can progress in severity to greatly limit mobility, and in advanced cases leads to frank ischemia with pain at rest. It is estimated that 12 to 15 million people in the United States are diagnosed with PAD, with a much larger population that is undiagnosed. The presence of PAD predicts a 50% to 1500% increase in morbidity and mortality, depending on severity. Treatment of patients with PAD is limited to modification of cardiovascular disease risk factors, pharmacological intervention, surgery, and exercise therapy. Extended exercise programs that involve walking approximately five times per week, at a significant intensity that requires frequent rest periods, are most significant. Preclinical studies and virtually all clinical trials demonstrate the benefits of exercise therapy, including improved walking tolerance, modified inflammatory/hemostatic markers, enhanced vasoresponsiveness, adaptations within the limb (angiogenesis, arteriogenesis, and mitochondrial synthesis) that enhance oxygen delivery and metabolic responses, potentially delayed progression of the disease, enhanced quality of life indices, and extended longevity. A synthesis is provided as to how these adaptations can develop in the context of our current state of knowledge and events known to be orchestrated by exercise. The benefits are so compelling that exercise prescription should be an essential option presented to patients with PAD in the absence of contraindications. Obviously, selecting for a lifestyle pattern that includes enhanced physical activity prior to the advance of PAD limitations is the most desirable and beneficial.

Indexed as

Adaptation, PhysiologicalAnimalsCapillariesCollateral CirculationExercise TherapyHumansMitochondria, MuscleMuscle, SkeletalNeovascularization, PathologicPeripheral Vascular DiseasesQuality of LifeRegional Blood FlowVasodilationWalking

Identifiers

PMID23720270
PMCPMC3767482
OpenAlexW1830359444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.